美医保拟覆盖礼来(LLY.US)诺和诺德(NVO.US)GLP-1减肥药,2026年起试点落地

智通财经08-01
【美医保拟覆盖礼来(LLY.US)诺和诺德(NVO.US)GLP-1减肥药,2026年起试点落地】智通财经APP获悉,特朗普政府正计划通过一项为期五年的试点项目,为部分医疗保险和医疗补助计划参保者提供减肥药物费用报销。此消息推动减肥药制造商礼来公司(LLY.US)和诺和诺德公司(NVO.US)周五盘前股价均上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment